Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations

Phase 1

• Registration Number: PER-002-03
• Lead Sponsor: ELI LILLY INTERAMERICA INC.,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2003-02-27
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1) were male and at least 18 years of age; 2) have signed informed consent; 3) had a history of DE for at least 3 months; 4) were users of sildenafil at a stable dose for 6 weeks or more; 5) having anticipated having the same sexual partner during the study to record the answers to the efficacy questionnaires; 6) to have agreed not to use any other treatment for ED throughout the study except study medication.

Exclusion Criteria

Presenting impotence caused by other primary sexual disorders including premature ejaculation or impotence caused by an untreated endocrine disease.
Have a history of radical prostatectomy
Have a history of a penile implant.
Having a clinically significant deformity in the penis in the opinion of the
investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified